Pura Vida Investments, LLC Altimmune, Inc. Call Options Transaction History

Pura Vida Investments, LLC

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2021 Aug 16, 2021	SELL	$9.85 - $16.46 $985,000 - $1.65 Million	-100,000 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$12.71 - $24.31 $1.27 Million - $2.43 Million	100,000 New	100,000 $1.41 Million

208

39.5M

1.94M

1.38M

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $315M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.